The product can not be sold in a country where it is illegal.
Buy MPHP for sale online from USA vendor
Specification
Product Name:
MPHP
IUPAC Name:
((RS)-1-(4-methylphenyl)-2-(1-pyrrolidinyl)-1-hexanone
Other Names:
4'-Methyl-α-pyrrolidinohexiophenone
Cas Number:
325122-32-1
Molecular Formula:
C17H25NO
Molar Mass:
259.385 g/mol
Effect:
stimulant, psychedelic
Purity of the substance:
≥99.8%
Physical properties:
Crystals
In Stock
Shipping:
- FREE 7 days from China
- INSURANCE option is local shipping from distributor in your country.
FREE & 3 Day Shipping
Payments: WU, MG, Bank Transfer , Pay with Bitcoin - get
10% OFF
Get FREE five samples 2 grams each for the main order.
What is MPHP?
MPHP (Methoxypyrrolidinohexaphenone) is a synthetic stimulant that belongs to a class of substances called cathinones. It is chemically similar to other synthetic drugs like MDPV and alpha-PVP. Often sold as a research chemical, it is typically found in powdered form and is sometimes used recreationally or in the production of designer drugs. It is important to note that MPHP is not approved for medical use and can have dangerous effects.
Is MPHP legal?
The legality of MPHP varies by country and region. In many places, it is considered a controlled substance and is illegal to possess, distribute, or manufacture. MPHP is often classified as a research chemical, and its legal status can change as authorities regulate new psychoactive substances. Always check local laws to ensure compliance.
What are the effects of MPHP?
MPHP acts as a stimulant, leading to effects similar to other cathinones and amphetamines. Users may experience heightened alertness, increased energy, euphoria, and talkativeness. However, it can also cause negative side effects such as anxiety, paranoia, agitation, and cardiovascular issues like increased heart rate and blood pressure.
How long do the effects of MPHP last?
The effects of MPHP typically last from 3 to 6 hours, depending on the dose, individual metabolism, and other factors. The peak effects generally occur within the first 1 to 2 hours after ingestion. However, some residual effects may linger for several hours after the primary effects wear off.
What are the dangers of using MPHP?
MPHP carries significant risks, including overdose, addiction, and dangerous health effects. The drug can cause severe cardiovascular stress, leading to elevated heart rates, high blood pressure, and possible heart failure. Long-term use may result in psychological issues such as anxiety, depression, and hallucinations. Additionally, since MPHP is often produced in unregulated environments, its purity and potency can vary, increasing the risk of adverse reactions.
How is MPHP usually consumed?
MPHP is typically consumed orally, snorted, or vaporized. When taken orally, the effects are slower to onset, while snorting or vaporizing can lead to faster, more intense effects. However, these methods also increase the risk of harm due to the rapid absorption of the substance.
Can MPHP be detected in drug tests?
Yes, MPHP can be detected in drug tests, though not all standard tests are designed to detect synthetic cathinones. Specialized tests, such as those used for research chemicals, are required to detect MPHP. The drug can be present in urine, blood, and hair samples, depending on the type of test used.
What should I do if I suspect someone has overdosed on MPHP?
If you suspect someone has overdosed on MPHP, it is critical to seek medical attention immediately. Symptoms of an overdose may include severe agitation, chest pain, rapid heartbeat, confusion, seizures, or loss of consciousness. Call emergency services right away and provide them with information about the substance involved.
Are there any known interactions with other substances?
MPHP can interact dangerously with other drugs, including alcohol, prescription medications, and other stimulants. Combining MPHP with substances like benzodiazepines, opioids, or alcohol can increase the risk of overdose, respiratory depression, and other life-threatening effects. Always avoid mixing substances without consulting a healthcare professional.
What are the withdrawal symptoms of MPHP?
Withdrawal from MPHP can lead to several symptoms, including fatigue, depression, anxiety, irritability, and cravings for the substance. Users may also experience physical symptoms such as headaches, muscle aches, and difficulty sleeping. A healthcare provider can assist in managing withdrawal symptoms and providing appropriate treatment.
Is there any treatment for MPHP addiction?
Yes, treatment for MPHP addiction typically involves behavioral therapy, counseling, and support groups. Cognitive-behavioral therapy (CBT) is commonly used to help individuals address the underlying psychological factors contributing to substance use. Detoxification and medical supervision may be required for those with severe dependencies.
Can MPHP cause long-term damage?
Long-term use of MPHP can cause significant psychological and physical damage. Chronic use has been linked to memory loss, cognitive impairment, and mental health disorders such as paranoia, anxiety, and depression. The drug's stimulant effects can also lead to lasting damage to the cardiovascular system and other organs.
How can I prevent MPHP abuse?
To prepare the content, the following materials were used:
- FDA Substance Registration System
- Hazardous Substances Data Bank. National Library of Medicine. 28 August 2008. Retrieved 22 August 2014. 3,4-Methylenedioxymethamphetamine
- Liver transplant modulates gut microbial dysbiosis and cognitive function in cirrhosis. PDF . By HoChong Gilles, Scott C Matherly, Mohammed S Siddiqui, Puneet Puri...
- Differential impact of hyponatremia and hepatic encephalopathy on health-related quality of life and brain metabolite abnormalities in cirrhosis . By Jasmohan Bajaj
- An overview of alcohol and other drug issues
- Medicating the mind: a Kantian analysis of overprescribing psychoactive drugs B A Manninen
- The pharmacological basis of opioids Carla Ghelardini, Lorenzo Di Cesare Mannelli and Enrica Bianchi
- Ask Dr. Shulgin Online ARCHIVE: June 3, 2004
- Inhibition of plasma membrane monoamine transporters by β-ketoamphetamines. Nicholas V Cozzi, Michael KSievert, Alexander T Shulgin, Peyton JacobIII, Arnold Eruoho
- Schedules of Controlled Substances: Placement of Methylone Into Schedule I
- Bioanalysis of new designer drugs. Wohlfarth A, Weinmann W.
- New Psychoactive Substances (including synthetic cannabinoids, mephedrone, and more)
- Future Synthetic Drugs of Abuse. Donald A. Cooper. Drug Enforcement Administration McLean, Virginia
- Designer drugs: a medicinal chemistry perspective. F. Ivy Carroll Anita H. Lewin S. Wayne Mascarella Herbert H. Seltzman P. Anantha Reddy
- Synthetic cannabinoids in Europe
- Pharmacological Effects of MDMA in Man. By Enno Freye
- Drug Use in Relation to Outcome of Mammography Screening. von Euler-Chelpin M, Wu W, Vejborg and Lynge E
- DEA Drug Scheduling
- Electrophysiological Effects of Trace Amines on Mesencephalic Dopaminergic Neurons.Ada Ledonne, Nicola Berretta, Alessandro Davoli, Giada Ricciardo Rizzo, Giorgio Bernardi and Nicola Biagio Mercuri
- Electrophysiological evidence for a reciprocal interaction between amphetamine and cocaine-related drugs on rat midbrain dopaminergic neurons.Scarponi M, Bernardi G, Mercuri NB.
- Overdose of Drugs for Attention-Deficit Hyperactivity Disorder: Clinical Presentation, Mechanisms of Toxicity, and Management. Henry A. Spiller, author Hannah L. Hays Alfred Aleguas.
- Dose-dependent effectiveness of wheel running to attenuate cocaine-seeking: impact of sex and estrous cycle in rats. Peterson AB, Hivick DP, Lynch WJ.r.
- FDA Drug Safety Communication: Safety Review Update of Medications used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) in children and young adults
- ADHD Medications and Risk of Serious Cardiovascular Events in Young and Middle-aged Adults
- Controlled Substances Act
- The Art of Drug Synthesis (Wiley Series on Drug Synthesis)
- Cannabis: domestic cultivation widespread
- A review of the influence of functional group modifications to the core scaffold of synthetic cathinones on drug pharmacokinetics
Other Products:

